NCT04278846View on ClinicalTrials.gov

Efficacy of Liposomal Bupivacaine for Prolonged Postoperative Analgesia in Patient Undergoing Breast Reconstruction With Tissue Expander

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 22, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

May 15, 2019

Conditions
Pain, PostoperativeMammaplasty
Interventions
DRUG

Depofoam bupivacaine

The study drug Depofoam bupivacaine will be administered into the right and/or left breast of each patient 30 minutes prior to the creation of the subpectoral muscle pocket.

DRUG

Bupivacaine hydrochloride (HCl)

The study drug bupivacaine HCl will be administered into the right and/or left breast of each patient 30 minutes prior to the creation of the subpectoral muscle pocket.

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

Sponsors
All Listed Sponsors
collaborator

Pacira Pharmaceuticals, Inc

INDUSTRY

lead

The Cleveland Clinic

OTHER

NCT04278846 - Efficacy of Liposomal Bupivacaine for Prolonged Postoperative Analgesia in Patient Undergoing Breast Reconstruction With Tissue Expander | Biotech Hunter | Biotech Hunter